Shanda Asset Management Holdings’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-30,500
Closed -$140K 90
2020
Q2
$140K Buy
+30,500
New +$140K 0.01% 73